Go Backs
HomeCategoriesStatesCheck Your Home
Go Backs

Track product recalls and safety alerts from CPSC, FDA, NHTSA, and USDA. Stay informed and keep your family safe.

Browse

  • Categories
  • States
  • Check Your Home
  • Risk Levels

Agencies

  • CPSC
  • FDA Food
  • FDA Drug
  • FDA Device
  • FDA Veterinary
  • NHTSA
  • USDA

Company

  • About
  • FAQ
  • Contact
  • Terms of Service
  • Privacy Policy
Buy Me a Coffee

Recall data is sourced from official U.S. government agencies (CPSC, FDA, NHTSA, USDA) and processed using AI to improve readability. This site is not affiliated with or endorsed by any government agency. Always refer to the original agency notice for authoritative information.

© 2026 Go Backs. All rights reserved.

Critical RiskFDA Drug
Medications & Supplements/Dietary Supplements

Umary Hyaluronic Acid Caplets Recalled for Undeclared Diclofenac and Omeprazole

Agency Publication Date: August 5, 2024
Share:
Sign in to monitor this recall

Summary

MAIN PRODUCTS INC is recalling approximately 57,340 bottles of Umary Acido Hialuronico (Hyaluronic Acid) 850 mg caplets because FDA testing found the product contains undeclared pharmaceutical ingredients. The product, which is marketed as a dietary supplement in 30-count bottles, was found to be tainted with diclofenac and omeprazole. All lots of this product that are currently within their expiration date are included in this recall.

Risk

The undeclared diclofenac is a non-steroidal anti-inflammatory drug (NSAID) that can increase the risk of heart attack, stroke, and serious gastrointestinal damage, especially when taken with other medications. The undeclared omeprazole is a proton pump inhibitor that can cause significant drug interactions and may mask serious underlying stomach conditions.

What You Should Do

  1. This recall affects all lots of Umary Acido Hialuronico (Hyaluronic Acid) 850 mg caplets packaged in 30-count bottles that are within their expiration date.
  2. Identify the product by looking for the 'Umary' brand name and 'Acido Hialuronico' or 'Hyaluronic Acid' on the black and light blue label.
  3. If you have health concerns, contact your healthcare provider or pharmacist. Return any unused product to the place of purchase for a refund, throw it away, or contact the manufacturer for further instructions.
  4. Call the FDA Consumer Complaint hotline at 1-888-723-3332 (1-888-SAFEFDA) or visit www.fda.gov/safety/recalls for additional information regarding this recall.

Your Remedy Options

You have 2 options:

💰Option 1: Full Refund
How to: Contact your healthcare provider or pharmacist for guidance, or return any unused product to the place of purchase for a refund
🗑️Option 2: Dispose of Product
How to: Throw the product away. For prescription medications, a DEA take-back location or pharmacy mail-back program is preferred when available.

Affected Products

Product: Umary Acido Hialuronico (Hyaluronic Acid)
Variants: 850 mg, 30-count bottle
Lot Numbers:
All lots within expiry

Marketed as a dietary supplement; FDA analysis found product to be tainted with undeclared Diclofenac and Omeprazole.

Product Images

“Umary Acido Hialuronico, Suplemento Alimenticio, 30 Capletas, front label”

“Umary Acido Hialuronico, Suplemento Alimenticio, 30 Capletas, front label”

“Nutrion information, back label”

“Nutrion information, back label”

“Suggested Use information, www.main-products.com, back label”

“Suggested Use information, www.main-products.com, back label”

“Umary USA Hyaluronic Acid Dietary Supplement, 30 capsules”

“Umary USA Hyaluronic Acid Dietary Supplement, 30 capsules”

Additional Information

Agency: Food and Drug Administration (FDA)
Event ID: 94962
Status: Active
Manufacturer: MAIN PRODUCTS INC
Sold By: Retailers nationwide
Manufactured In: United States
Units Affected: 57, 340 bottles
Distributed To: Nationwide

Were You Affected by This Recall?

If you or a family member were harmed by this recalled product, you may have legal rights. Consider consulting a consumer protection attorney to understand your options for compensation.

Find an Attorney

This is general information, not legal advice. Go Backs is not a law firm and does not provide legal services.

AI-Enhanced Content: The summary, action steps, and risk assessment on this page were generated by AI from official government recall data to improve readability. This is not legal or medical advice. Always refer to the official agency sources below for authoritative information.

Sources: FDA iRES · FDA Press Release · Raw API Response

openFDA Disclaimer: This recall information is sourced from the openFDA API. Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. Refer to the openFDA terms of service for more information.